Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adb0e564374fedf34b36103d36e6455a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96433 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
filingDate |
2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27120d273663263e2e9ce6842963d291 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dce2d6839914b70279f373fe79b8187f |
publicationDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016305966-A1 |
titleOfInvention |
Identification of anticoagulants in a sample |
abstract |
The present invention is directed to a novel method of determining inhibitors of proteolytically active coagulation factors, referred to herein as anticoagulants, in a sample, in particular the qualitative detection of direct thrombin and factor Xa inhibitors in a sample. The method of the present invention allows a qualitative determination of the nature anticoagulants present in a sample. This can be achieved with only one coagulation-based test. The method can be used in a test kit, including a point-of-care system. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4220177-A3 |
priorityDate |
2013-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |